Sign in
Taking peopleNo phase

Effect of Oral Melatonin Versus Intraoperative Lidocaine Infusion on Incidence of Postoperative Delirium in Elderly Patients Undergoing Total Hip Arthroplasty

Key facts

Who runs it
Tanta University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
135 people, planned
Started
15 Jan 2025
Planned end
1 Oct 2026
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Melatonin
  • Lidocaine
  • Placebo
Record updated
15 April 2025

Who can take part

Age
65 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Elderly patients aged >65 years old undergoing unilateral total hip arthroplasty
  • Patients with body mass index (BMI) (18-30) kg/m2
  • American Society of Anesthesiologists (ASA) physical status I-III, scheduled to undergo unilateral total hip arthroplasty

Who cannot take part

  • Symptomatic cerebrovascular disease (such as previous stroke)
  • Alcohol dependence or drug abuse
  • Redo surgery or infectious complications
  • CNS medications (antipsychotics, anticonvulsants, antiparkinsonian, antidepressants)
  • History of mental illness or scoring less than 8 using abbreviated mental test (AMT) before operation
  • Obvious sinus bradycardia (heart rate of <50 beats per minute) or other serious cardiovascular diseases
  • History of liver and kidney dysfunction
  • Allergy to lidocaine or melatonin
  • Metabolic disorders and fluid, electrolytes disturbances
  • History of deep vein thrombosis

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is to assess the effect of oral melatonin versus intraoperative lidocaine infusion on incidence of postoperative delirium in elderly patients undergoing total hip arthroplasty under spinal anesthesia.

The 3 groups in the trial

  • Melatonin groupTreatment being tested

    Patients will receive one capsule of melatonin (5mg) orally the night before surgery at 9 pm, the night of the operation, and two nights after the surgical operation at 9 pm, also the patients will receive 10 ml bolus of saline intravenous (IV) over 10 min before induction of anesthesia, then continuous infusion of saline (20 ml/hr) until the end of surgery.

    Treatment: Melatonin

  • Lidocaine groupTreatment being tested

    Patients will receive a bolus (10 ml) of intravenous lidocaine (1mg/kg) diluted with saline over 10 min before induction of anesthesia. Continuous infusion of 1.5 mg/kg/hr of intravenous lidocaine diluted with saline (20 ml/hr) will be administered until the end of the surgery, also will receive placebo capsule the night before surgery at 9 pm, the night of operation and two nights after the surgical operation at 9 pm.

    Treatment: Lidocaine

  • Control groupPlacebo, for comparison

    Patients will receive a bolus (10 ml) of saline over 10 min before induction of anesthesia, then continuous infusion of saline (20 ml/hr) and placebo capsule the night before surgery at 9 pm, the night of the operation and two nights after the surgical operation at 9 pm.

    Treatment: Placebo

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Oral Melatonin Versus Intraoperative Lidocaine Infusion on Incidence of Postoperative Delirium in Elderly Patients Undergoing Total Hip Arthroplasty: Prospective Randomized Controlled Blinded Study
Record updated
15 April 2025